• Lyme's Heart Risk; Osler's RVUs; FDA's Bar for HF Drugs

    Athersys is using a stroke survivor's recovery story to distract attention from its stem cell treatment's clinical trial flop, STAT charges. (subscription required)

    Lessons from pediatricians battling vaccine hesitancy can help combat statin doubts, as a viewpoint in JAMA Cardiology outlines.

    Sir William Osler, the "father of modern medicine," probably wouldn't have measured up on Relative Value Units. (Annals of Internal Medicine)

    In hopes of stimulating drug development for heart failure, the FDA released draft guidance saying that symptom or physical function improvements could lead to approval in the absence of survival or hospitalization benefits. A workshop is planned for July 26 to address trial endpoints.

    Meanwhile, Sanofi announced it will stop R&D in cardiology. (Reuters)

    A stick-on heart rate and EKG patch, the BraveHeart Life Sensor Cardiac Monitoring system, gained FDA clearance for healthcare setting use. (MedGadget)

    "Electronic tattoo": a prototype soft patch performed both ECG and seismocardiography in an early study. (Cardiovascular Business)

    blood pressure-monitoring sneaker? Under Armour thinks it could happen. (Baltimore Business Journal)

    The Eko Core algorithm app for use with a digital stethoscope confirmed suspected aortic stenosis with 97.2% sensitivity and 86.4% specificity in a study presented at the American Society of Echocardiography meeting in Portland, the company announced.

     

    Sales of prescription omega-3 pill icosapent ethyl (Vascepa) have already doubled since the REDUCE-IT trial presentation last year, and Amarin expects more with a formal label update by late September. (STAT)

    Infection, particularly of the urinary tract, was linked to acute ischemic stroke in a population-based study. (Cardiovascular Business)

    The American Heart Association announced Post-Acute Care Heart Failure Certificationfor skilled nursing facilities with the aim to cut heart failure readmissions.

    Long-term exposure to air pollution in China appears to independently predict coronary artery calcium. (JAMA Network Open)

    Also in JAMA Network Open, titin-truncating gene variants were linked to arrhythmia in dilated cardiomyopathy among patients with an implanted cardiac device.

    Source:

    Read the original article on Medpage Today: Lyme's Heart Risk; Osler's RVUs; FDA's Bar for HF Drugs

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details